AAV gene therapy (Tamid Bio)

N/A

Report date: 2025/03/14 16:43:33

Base Information

Drug NameAAV gene therapy (Tamid Bio)
Drug Alias NameAAV gene therapy (University of North Carolina)
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsKeratoplasty rejection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of North Carolina, Greensboro
China Registration ClassN/A

Develop Information

Active CompaniesTamid Bio Inc
Inactive CompaniesN/A
Active IndicationsKeratoplasty rejection
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A